Bristol Myers Squibb reported $1.61B in Net Income for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Net Income Change
Abbott ABT:US USD 1.03B 402M
Abbvie ABBV:US USD 3.95B 3.03B
ALKERMES ALKS:US USD -63974000 33.84M
Amgen AMGN:US USD 2.14B 826M
AstraZeneca AZN:LN USD 1.64B 1.28B
Astrazeneca AZN:US USD 1.64B 1.28B
Biogen BIIB:US USD 1.13B 76.7M
Bristol Myers Squibb BMY:US USD 1.61B 185M
Eli Lilly And LLY:US USD 1.45B 499.2M
Endo International Ordinary Shares ENDP:US USD -722169000 1.16B
Gilead Sciences GILD:US USD 1.79B 645M
GlaxoSmithKline GSK:LN GBP 10.32B 9.48B
Horizon Pharma HZNP:US USD 135.84M 74.86M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
JAZZ PHA JAZZ:US USD -19648000 54.31M
Johnson & Johnson JNJ:US USD 3.52B 938M
Lannett LCI:US USD -28019000 65.28M
Medtronic MDT:US USD 428M 502M
Merk MRK:US USD 3.25B 696M
Novartis NOVN:VX USD 1.57B 121M
Perrigo Ordinary Shares PRGO:US USD -49400000 15.7M
Pfizer PFE:US USD 8.61B 1.3B
Prestige Brands PBH:US USD 51.02M 4.25M
Regeneron Pharmaceuticals REGN:US USD 1.32B 463.6M
Revance Therapeutics RVNC:US USD -84693000 23.26M
Roche Holding ROG:VX 8.53B 2.4B
Teva Pharmaceutical Industries TEVA:US USD 55M 288M
United Therapeutics UTHR:US USD 239.3M 123.3M
Zoetis ZTS:US USD 529M 0